Cancer clinical trials in the region Auvergne-Rhône-Alpes
360 currently recruiting clinical trials
Looking for clinical trials?
Clinical trial search is a complex process, with countless criteria to consider. Our AI assistant navigates this complexity with precise, expert-level analysis of the most relevant trials based on your medical profile. Our database is fully up to date, so you see only actively recruiting sites. It's fast and easy:
- Create your account
- Copy-paste your latest medical report
- Our AI-based assistant does the rest for you
Whether you are a patient or a doctor, create an account to find and apply for the most relevant clinical trials:
Phase 2
Lymphoma
#NCT05463263
B cell lymphoma
T cell lymphoma
None
2
3 or more
Systemic Treatment-Naive
Centre Léon Bérard (Lyon)
Step Pharma, SAS
Phase 2
Kidney cancer
#NCT04299646
Clear cell carcinoma
Metastatic
1
2
0
1 or 2
Systemic Treatment-Naive
Immunotherapy
Targeted therapy
Centre de Radiothérapie Marie Curie (Valence)
Centre François Baclesse
Phase 2
Lung cancer
#NCT05742607
NSCLC (Non-Small Cell Lung Cancer)
Localized
None
Systemic Treatment-Naive
ALK
EGFR
Immunotherapy
Targeted therapy
Centre Léon Bérard (Lyon)
Innate Pharma
Phase 2
Bladder / Urinary Tract / Urethral cancer
#NCT04617756
Upper excretory tract cancer
Urothelial carcinoma
Localized
None
Systemic Treatment-Naive
Surgery
Hôpital Lyon Sud - Hospices Civils de Lyon (Pierre-Bénite)
Centre Hospitalier Universitaire de Nîmes
Phase 1 / Phase 2
Lung cancer
#NCT06128551
Phase 1b expansion de dose et phase 2 cohortes CBNPC non naïs d'inhibiteurs de KRAS G12C
NSCLC (Non-Small Cell Lung Cancer)
Locally Advanced
Metastatic
KRAS G12C
1
2
3 or more
Immunotherapy
Chemotherapy
Targeted therapy
Systemic Treatment-Naive
Centre Léon Bérard (Lyon), Hôpital Louis Pradel (Bron )
Revolution Medicines, Inc.
Phase 1 / Phase 2
Breast cancer
Lung cancer
Prostate cancer
Colon cancer
Rectal cancer
Anal cancer
Kidney cancer
Pancreas cancer
Liver and bile duct cancer
Bladder / Urinary Tract / Urethral cancer
Stomach and esophageal cancer
Endometrial cancer
Ovarian / Fallopian tubes / Peritoneum cancer
#NCT06128551
Phase 1b extension de dose et phase 2 cohortes tumeurs solides naïves d'inhibiteurs de KRAS G12C
Locally Advanced
Metastatic
Metastatic Castration-resistant
KRAS G12C
1
2
3 or more
Systemic Treatment-Naive
Targeted therapy
Centre Léon Bérard (Lyon), Hôpital Louis Pradel (Bron )
Revolution Medicines, Inc.
Phase 1 / Phase 2
Breast cancer
Lung cancer
Prostate cancer
Colon cancer
Rectal cancer
Anal cancer
Kidney cancer
Pancreas cancer
Liver and bile duct cancer
Bladder / Urinary Tract / Urethral cancer
Stomach and esophageal cancer
Endometrial cancer
Ovarian / Fallopian tubes / Peritoneum cancer
#NCT06128551
Phase 1b Escalade de dose
Locally Advanced
Metastatic
Metastatic Castration-resistant
KRAS G12C
1
2
3 or more
Systemic Treatment-Naive
Centre Léon Bérard (Lyon), Hôpital Louis Pradel (Bron )
Revolution Medicines, Inc.
Phase 1 / Phase 2
Breast cancer
#NCT05768139
#2023-000442-41
Cohortes combinaison extension de dose cancer du sein RH+ (parties 2 et 3)
HER2 Negative
HER2 Low
HR Positive
Locally Advanced
Metastatic
PIK3CA
1
2
3 or more
Systemic Treatment-Naive
Centre Léon Bérard (Lyon)
Eli Lilly et compagnie
Phase 1 / Phase 2
Breast cancer
Lung cancer
Prostate cancer
Colon cancer
Rectal cancer
Anal cancer
Kidney cancer
Pancreas cancer
Liver and bile duct cancer
Bladder / Urinary Tract / Urethral cancer
Stomach and esophageal cancer
Endometrial cancer
Ovarian / Fallopian tubes / Peritoneum cancer
#NCT05768139
#2023-000442-41
Cohortes monothérapie (partie 1)
HR Positive
Locally Advanced
Metastatic
PIK3CA
1
2
3 or more
Centre Léon Bérard (Lyon)
Eli Lilly et compagnie
Phase 1 / Phase 2
Endometrial cancer
#NCT04590326
Cohortes endomètre
Locally Advanced
Metastatic
1
2
3 or more
Immunotherapy
Chemotherapy
Systemic Treatment-Naive
Hôpital Lyon Sud - Hospices Civils de Lyon (Pierre-Bénite)
Regeneron Pharmaceuticals